Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Fusciello

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Plos One|December 14, 2016
MATE2 Expression Is Associated with Cancer Cell Response to MetforminSanjana Chowdhury, Eric Yung, Melania Pintilie, et al.
Cancer Research|February 29, 2020
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer ImmunotherapySiri Tähtinen, Sara Feola, Cristian Capasso, et al.
Nanoscale|January 14, 2020
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarctionGiulia Torrieri, Flavia Fontana, Patrícia Figueiredo, et al.
Elife|March 22, 2022
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccinesSara Feola, Jacopo Chiaro, Beatriz Martins, et al.
Nature Communications|December 19, 2019
Artificially cloaked viral nanovaccine for cancer immunotherapyManlio Fusciello, Flavia Fontana, Siri Tähtinen, et al.
Journal for Immunotherapy of Cancer|August 7, 2021
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoidsFiras Hamdan, Erkko Ylösmäki, Jacopo Chiaro, et al.
Journal for Immunotherapy of Cancer|November 12, 2025
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapySalvatore Russo, Yvonne Giannoula, Sara Feola, et al.
Cancer Immunology Research|June 9, 2021
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human MelanomaJacopo Chiaro, Henna H E Kasanen, Thomas Whalley, et al.
Oncoimmunology|October 1, 2024
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenovirusesMichaela Feodoroff, Firas Hamdan, Gabriella Antignani, et al.
Nature Communications|November 4, 2023
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumorsJacopo Chiaro, Gabriella Antignani, Sara Feola, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Plos One|December 14, 2016
MATE2 Expression Is Associated with Cancer Cell Response to MetforminSanjana Chowdhury, Eric Yung, Melania Pintilie, et al.
Cancer Research|February 29, 2020
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer ImmunotherapySiri Tähtinen, Sara Feola, Cristian Capasso, et al.
Nanoscale|January 14, 2020
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarctionGiulia Torrieri, Flavia Fontana, Patrícia Figueiredo, et al.
Elife|March 22, 2022
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccinesSara Feola, Jacopo Chiaro, Beatriz Martins, et al.
Nature Communications|December 19, 2019
Artificially cloaked viral nanovaccine for cancer immunotherapyManlio Fusciello, Flavia Fontana, Siri Tähtinen, et al.
Journal for Immunotherapy of Cancer|August 7, 2021
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoidsFiras Hamdan, Erkko Ylösmäki, Jacopo Chiaro, et al.
Journal for Immunotherapy of Cancer|November 12, 2025
Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapySalvatore Russo, Yvonne Giannoula, Sara Feola, et al.
Cancer Immunology Research|June 9, 2021
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human MelanomaJacopo Chiaro, Henna H E Kasanen, Thomas Whalley, et al.
Oncoimmunology|October 1, 2024
Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenovirusesMichaela Feodoroff, Firas Hamdan, Gabriella Antignani, et al.
Nature Communications|November 4, 2023
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumorsJacopo Chiaro, Gabriella Antignani, Sara Feola, et al.
Pageof 4